Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,419 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)

NCT02447666

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • St. Anna Kinderkrebsforschung, CHILDREN'S CANCER RESEARCH INSTITUTE Vienna, Austria
  • Hopital Universitaire des Enfants Brussels, Belgium
  • University Hospital Ghent Ghent, Belgium
  • University Hospital Motol Prague, Czechia
View all 39 locations
View Trial Details
Completed

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00104858

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +25 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Rigshospitalet University Hospital Copenhagen, Denmark
View Trial Details
Completed

Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia

NCT00537030

Conditions
Adult Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 43 locations
View Trial Details
Completed

A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)

NCT00510133

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Washington University School of Medicine, Siteman Cancer Center St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

NCT00910910

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • California Cancer Associates for Research and Excellence cCARE Escondido, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Cancer Center of Central Connecticut Southington, Connecticut, United States
View all 165 locations
View Trial Details
Completed

A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia

NCT01358734

Conditions
Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations
  • (210) University of Arizona Cancer Center Tucson, Arizona, United States
  • (180) University of California, San Diego La Jolla, California, United States
  • (240) Cedars-Sinai Medical Center Los Angeles, California, United States
  • (215) Hematology Oncology Medical Group Orange, California, United States
View all 30 locations
View Trial Details
Completed

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia

NCT00634881

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany
  • Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany
  • Universitatsklinikum Heidelberg Heidelberg, Germany
  • Klinikum Lippe - Lemgo Lemgo, Germany
View Trial Details
Completed

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT01008462

Conditions
B-Cell Prolymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +51 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions